loader

Disclaimer

The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above
Close

Search

See all results for ""
KP

Kevin Peter

, Delhi

Counsel | Corporate & Commercial

education

  • B.A., LL.B (Corporate Law Hons.) from National Law University, Jodhpur, India (2013).

Kevin is a Counsel in the Delhi office of Khaitan & Co in the Corporate M&A and Private Equity practice group.  Kevin specialises in advising corporate clients and financial sponsors in a range of transactions – structuring and investment strategies, exit, buyouts etc.

His focus areas include healthcare, life sciences, food & agriculture, Fintech and IT & ITES sector

Professional Affiliations

  • Bar Council of Maharashtra and Goa

Representative Matters

Kevin Peter has represented and advised the following clients

Renault Group B.V.

Advised on the entire shareholding of Renault Nissan Automotive India Private Limited from Nissan Motor Co. Limited and Nissan Overseas Investments B.V.

Manipal Hospitals

Advised on acquisition of a majority stake in AMRI Hospitals Limited, a hospital group operating several multi-specialty hospital assets in East India.

Artemis Medicare Services Limited

Advised on proposed acquisition of hospital assets in the Delhi NCR Region.

Mankind Pharma Limited

Advised on relation to acquisition of the formulations’ brands business from Panacea Biotec Pharma Limited.

Samara Capital

Advised on proposed acquisition of hospital assets in West India and Delhi NCR Region.

Asian Institute of Nephrology and Urology Private Limited

Advised on the selling shareholders (including the promoters) and HealthQuad Fund I in the secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd.